Answers are grounded in this paper and cite their sources.
Non-steroidal-anti-inflammatory drugs (NSAIDs) make a heterogenous pharmaco-therapeutic class of drugs among the most used drugs worldwide with various indications, modes of administration and increasing automedication. NSAIDs can cause acute liver injury with variable severity. The recent identification of genetic markers might facilitate the diagnosis and the prediction of hepatotoxicity risk.
No takes yet. Share an insight, caveat, or question.
Meunier et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: